The infiltration of CD8+ T cells was indicated to be significantly lower in MUC1-high tumors (BRCA, GBM, LGG, PAAD, THYM, and UCEC) and MUC16-high ovarian cancer, which was assessed by several prediction algorithms. The gene discussed is MUC1; the disease is glioblastoma.